Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

Affiliations

• ¹ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. tariqkewan@gmail.com.
• ² Department of Hematology and Medical Oncology, Yale University, New Haven, CT, USA. tariqkewan@gmail.com.
• ³ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
• ⁴ Systems Biology and Bioinformatics Department, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
• ⁵ Department of Biomedicine and Prevention, Ph.D. in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
• ⁶ Department of Clinical Hematology, CHRU de Nancy, Nancy, France.
• ⁷ Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
• ⁸ Department of Hematology and Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
• ⁹ Department of Internal Medicine, Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
• ¹⁰ Division of Hematology, Sylvester Cancer Center, University of Miami, Miami, FL, USA.
• ¹¹ MLL Munich Leukemia Laboratory, Munich, Germany.
• ¹² Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. visconv@ccf.org.
• ¹³ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. maciejj@ccf.org.